Table 3 Cox regression analyses of overall survival for OS patients.

From: Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients

Variables

Total (N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

p value

Hazard ratio (95% CI)

p value

Age (< 18 vs. >  = 18)

99

1.365 (0.605–3.081)

0.454

  

Gender (female vs. male)

99

1.024 (0.546–1.922)

0.940

  

Race (white vs. others)

75

0.754 (0.315–1.803)

0.525

  

Surgery (limb sparing vs. amputation)

58

1.376 (0.410–4.613)

0.606

  

Tumor side (right vs. left)

27

1.321 (0.494–3.529)

0.579

  

Primary site progression (yes vs. no)

50

1.769 (0.864–3.626)

0.119

  

Tumor region (distal vs. proximal)

60

2.321 (0.925–5.823)

0.073

  

Metastasis (yes vs. no)

99

3.679 (1.964–6.892)

 < 0.001

3.564 (1.883–6.743)

 < 0.001

EGFR (low vs. high)

99

1.942 (1.028–3.669)

0.041

2.203 (1.122–4.327)

0.022

SOCS1 (low vs. high)

99

2.274 (1.207–4.283)

0.011

2.323 (1.202–4.488)

0.012

CBS (high vs. low)

99

2.217 (1.176–4.180)

0.014

2.601 (1.321–5.118)

0.006